Aug 27 |
Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
|
Aug 20 |
Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award
|
Aug 19 |
Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
|
Aug 15 |
Jaguar Health Second Quarter 2024 Earnings: Misses Expectations
|
Aug 13 |
Jaguar Health, Inc. (JAGX) Q2 2024 Earnings Call Transcript
|
Aug 13 |
Earnings summary: Jaguar Health Q2 results miss estimates
|
Aug 13 |
Jaguar Health GAAP EPS of -$4.04 misses by $2.84, revenue of $2.72M misses by $0.71M
|
Aug 13 |
Jaguar Health Reports Second Quarter 2024 Financial Results
|
Aug 12 |
Jaguar Health Q2 2024 Earnings Preview
|
Aug 12 |
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients
|